author_facet Jäger, Katharina
Larribère, Lionel
Wu, Huizi
Weiss, Christel
Gebhardt, Christoffer
Utikal, Jochen
Jäger, Katharina
Larribère, Lionel
Wu, Huizi
Weiss, Christel
Gebhardt, Christoffer
Utikal, Jochen
author Jäger, Katharina
Larribère, Lionel
Wu, Huizi
Weiss, Christel
Gebhardt, Christoffer
Utikal, Jochen
spellingShingle Jäger, Katharina
Larribère, Lionel
Wu, Huizi
Weiss, Christel
Gebhardt, Christoffer
Utikal, Jochen
Cancers
Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
Cancer Research
Oncology
author_sort jäger, katharina
spelling Jäger, Katharina Larribère, Lionel Wu, Huizi Weiss, Christel Gebhardt, Christoffer Utikal, Jochen 2072-6694 MDPI AG Cancer Research Oncology http://dx.doi.org/10.3390/cancers11010076 <jats:p>Regulation of particular genes during the formation of neural crest (NC) cells is also described during progression of malignant melanoma. In this context, it is of paramount importance to develop neural crest models allowing the identification of candidate genes, which could be used as biomarkers for melanoma prognosis. Here, we used a human induced Pluripotent Stem Cells (iPSC)-based approach to present novel NC-associated genes, expression of which was upregulated in melanoma. A list of 8 candidate genes, based on highest upregulation, was tested for prognostic value in a tissue microarray analysis containing samples from advanced melanoma (good versus bad prognosis) as well as from high-risk primary melanomas (early metastasizing versus non or late-metastasizing). CD271, GLDC, and ERRFI1 showed significantly higher expression in metastatic patients who died early than the ones who survived at least 30 months. In addition, GLDC and TWIST showed a significantly higher immunohistochemistry (IHC) score in primary melanomas from patients who developed metastases within 12 months versus those who did not develop metastases in 30 months. In conclusion, our iPSC-based study reveals a significant association of NC marker GLDC protein expression with melanoma prognosis.</jats:p> Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis Cancers
doi_str_mv 10.3390/cancers11010076
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jYW5jZXJzMTEwMTAwNzY
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jYW5jZXJzMTEwMTAwNzY
institution DE-Zwi2
DE-D161
DE-Zi4
DE-Gla1
DE-15
DE-Pl11
DE-Rs1
DE-14
DE-105
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint MDPI AG, 2019
imprint_str_mv MDPI AG, 2019
issn 2072-6694
issn_str_mv 2072-6694
language English
mega_collection MDPI AG (CrossRef)
match_str jager2019expressionofneuralcrestmarkersgldcanderrfi1iscorrelatedwithmelanomaprognosis
publishDateSort 2019
publisher MDPI AG
recordtype ai
record_format ai
series Cancers
source_id 49
title Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_unstemmed Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_full Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_fullStr Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_full_unstemmed Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_short Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_sort expression of neural crest markers gldc and errfi1 is correlated with melanoma prognosis
topic Cancer Research
Oncology
url http://dx.doi.org/10.3390/cancers11010076
publishDate 2019
physical 76
description <jats:p>Regulation of particular genes during the formation of neural crest (NC) cells is also described during progression of malignant melanoma. In this context, it is of paramount importance to develop neural crest models allowing the identification of candidate genes, which could be used as biomarkers for melanoma prognosis. Here, we used a human induced Pluripotent Stem Cells (iPSC)-based approach to present novel NC-associated genes, expression of which was upregulated in melanoma. A list of 8 candidate genes, based on highest upregulation, was tested for prognostic value in a tissue microarray analysis containing samples from advanced melanoma (good versus bad prognosis) as well as from high-risk primary melanomas (early metastasizing versus non or late-metastasizing). CD271, GLDC, and ERRFI1 showed significantly higher expression in metastatic patients who died early than the ones who survived at least 30 months. In addition, GLDC and TWIST showed a significantly higher immunohistochemistry (IHC) score in primary melanomas from patients who developed metastases within 12 months versus those who did not develop metastases in 30 months. In conclusion, our iPSC-based study reveals a significant association of NC marker GLDC protein expression with melanoma prognosis.</jats:p>
container_issue 1
container_start_page 0
container_title Cancers
container_volume 11
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344820951285770
geogr_code not assigned
last_indexed 2024-03-01T17:13:41.677Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Expression+of+Neural+Crest+Markers+GLDC+and+ERRFI1+is+Correlated+with+Melanoma+Prognosis&rft.date=2019-01-11&genre=article&issn=2072-6694&volume=11&issue=1&pages=76&jtitle=Cancers&atitle=Expression+of+Neural+Crest+Markers+GLDC+and+ERRFI1+is+Correlated+with+Melanoma+Prognosis&aulast=Utikal&aufirst=Jochen&rft_id=info%3Adoi%2F10.3390%2Fcancers11010076&rft.language%5B0%5D=eng
SOLR
_version_ 1792344820951285770
author Jäger, Katharina, Larribère, Lionel, Wu, Huizi, Weiss, Christel, Gebhardt, Christoffer, Utikal, Jochen
author_facet Jäger, Katharina, Larribère, Lionel, Wu, Huizi, Weiss, Christel, Gebhardt, Christoffer, Utikal, Jochen, Jäger, Katharina, Larribère, Lionel, Wu, Huizi, Weiss, Christel, Gebhardt, Christoffer, Utikal, Jochen
author_sort jäger, katharina
container_issue 1
container_start_page 0
container_title Cancers
container_volume 11
description <jats:p>Regulation of particular genes during the formation of neural crest (NC) cells is also described during progression of malignant melanoma. In this context, it is of paramount importance to develop neural crest models allowing the identification of candidate genes, which could be used as biomarkers for melanoma prognosis. Here, we used a human induced Pluripotent Stem Cells (iPSC)-based approach to present novel NC-associated genes, expression of which was upregulated in melanoma. A list of 8 candidate genes, based on highest upregulation, was tested for prognostic value in a tissue microarray analysis containing samples from advanced melanoma (good versus bad prognosis) as well as from high-risk primary melanomas (early metastasizing versus non or late-metastasizing). CD271, GLDC, and ERRFI1 showed significantly higher expression in metastatic patients who died early than the ones who survived at least 30 months. In addition, GLDC and TWIST showed a significantly higher immunohistochemistry (IHC) score in primary melanomas from patients who developed metastases within 12 months versus those who did not develop metastases in 30 months. In conclusion, our iPSC-based study reveals a significant association of NC marker GLDC protein expression with melanoma prognosis.</jats:p>
doi_str_mv 10.3390/cancers11010076
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9jYW5jZXJzMTEwMTAwNzY
imprint MDPI AG, 2019
imprint_str_mv MDPI AG, 2019
institution DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 2072-6694
issn_str_mv 2072-6694
language English
last_indexed 2024-03-01T17:13:41.677Z
match_str jager2019expressionofneuralcrestmarkersgldcanderrfi1iscorrelatedwithmelanomaprognosis
mega_collection MDPI AG (CrossRef)
physical 76
publishDate 2019
publishDateSort 2019
publisher MDPI AG
record_format ai
recordtype ai
series Cancers
source_id 49
spelling Jäger, Katharina Larribère, Lionel Wu, Huizi Weiss, Christel Gebhardt, Christoffer Utikal, Jochen 2072-6694 MDPI AG Cancer Research Oncology http://dx.doi.org/10.3390/cancers11010076 <jats:p>Regulation of particular genes during the formation of neural crest (NC) cells is also described during progression of malignant melanoma. In this context, it is of paramount importance to develop neural crest models allowing the identification of candidate genes, which could be used as biomarkers for melanoma prognosis. Here, we used a human induced Pluripotent Stem Cells (iPSC)-based approach to present novel NC-associated genes, expression of which was upregulated in melanoma. A list of 8 candidate genes, based on highest upregulation, was tested for prognostic value in a tissue microarray analysis containing samples from advanced melanoma (good versus bad prognosis) as well as from high-risk primary melanomas (early metastasizing versus non or late-metastasizing). CD271, GLDC, and ERRFI1 showed significantly higher expression in metastatic patients who died early than the ones who survived at least 30 months. In addition, GLDC and TWIST showed a significantly higher immunohistochemistry (IHC) score in primary melanomas from patients who developed metastases within 12 months versus those who did not develop metastases in 30 months. In conclusion, our iPSC-based study reveals a significant association of NC marker GLDC protein expression with melanoma prognosis.</jats:p> Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis Cancers
spellingShingle Jäger, Katharina, Larribère, Lionel, Wu, Huizi, Weiss, Christel, Gebhardt, Christoffer, Utikal, Jochen, Cancers, Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis, Cancer Research, Oncology
title Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_full Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_fullStr Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_full_unstemmed Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_short Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
title_sort expression of neural crest markers gldc and errfi1 is correlated with melanoma prognosis
title_unstemmed Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis
topic Cancer Research, Oncology
url http://dx.doi.org/10.3390/cancers11010076